Table 2.
Moderators | TST | WASO | SE | N1 percentage | N2 percentage | SWS percentage | REM percentage | REM latency | PLMI | AI | AHI | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Sex (female%) | No. of comparison | 6 | 4 | 6 | 6 | 6 | 6 | 6 | 5 | 4 | 5 | 5 |
No. of H/C | 121/119 | 96/93 | 121/119 | 121/119 | 121/119 | 121/119 | 121/119 | 91/89 | 96/93 | 105/103 | 105/103 | |
Point estimate | 0.32 | −3.60 | 1.10 | −0.50 | 3.43 | 0.13 | −1.25 | −0.37 | −5.63 | 4.21 | −1.15 | |
SE | 4.47 | 9.10 | 4.67 | 2.78 | 2.75 | 4.20 | 4.27 | 4.09 | 11.09 | 7.77 | 3.82 | |
P | 0.94 | 0.69 | 0.81 | 0.83 | 0.21 | 0.98 | 0.77 | 0.93 | 0.61 | 0.59 | 0.76 | |
Mean age of HD patients | No. of comparison | 6 | 4 | 6 | 6 | 6 | 6 | 6 | 5 | 4 | 5 | 5 |
No. of H/C | 121/119 | 96/93 | 121/119 | 121/119 | 121/119 | 121/119 | 121/119 | 91/89 | 96/93 | 105/103 | 105/103 | |
Point estimate | −0.07 | 0.10 | −0.08 | 0.02 | −0.02 | −0.08 | −0.11 | 0.12 | 0.09 | 0.08 | −0.01 | |
SE | 0.04 | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.03 | 0.05 | 0.05 | 0.05 | 0.03 | |
P | 0.10 | 0.003 | 0.08 | 0.34 | 0.55 | 0.03 | <0.001 | 0.016 | 0.09 | 0.14 | 0.67 | |
BMI (kg/m2) | No. of comparison | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
No. of H/C | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 66/63 | 96/93 | 96/93 | 96/93 | |
Point estimate | 0.28 | −0.36 | 0.28 | −0.10 | 0.10 | 0.28 | 0.44 | −0.43 | −0.34 | −0.37 | 0.11 | |
SE | 0.25 | 0.13 | 0.26 | 0.13 | 0.14 | 0.24 | 0.13 | 0.20 | 0.20 | 0.20 | 0.13 | |
P | 0.26 | 0.006 | 0.28 | 0.43 | 0.47 | 0.25 | <0.001 | 0.03 | 0.08 | 0.07 | 0.36 | |
CAG repeats (n) | No. of comparison | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | 3 | 3 |
No. of H/C | 115/109 | 115/109 | 115/109 | 115/109 | 115/109 | 115/109 | 115/109 | 85/79 | 84/84 | 84/84 | 84/84 | |
Point estimate | −0.23 | 0.13 | −0.39 | 0.13 | 0.05 | −0.57 | −0.29 | 0.17 | 0.20 | 0.81 | −0.003 | |
SE | 0.39 | 0.24 | 0.36 | 0.13 | 0.18 | 0.24 | 0.26 | 0.17 | 1.05 | 0.88 | 0.29 | |
P | 0.56 | 0.58 | 0.28 | 0.33 | 0.76 | 0.017 | 0.26 | 0.33 | 0.85 | 0.36 | 0.99 | |
Disease severity | ||||||||||||
Excluding Piano study | No. of comparison | 6 | 4 | 6 | 6 | 6 | 6 | 6 | 6 | 3 | 4 | 4 |
No. of H/C | 122/114 | 97/88 | 122/114 | 122/114 | 122/114 | 122/114 | 122/114 | 122/114 | 66/63 | 75/73 | 75/73 | |
SMD | −0.109 | 0.520** | −0.615*** | 0.386** | −0.006 | −0.286 | −0.402* | 0.425* | 0.260 | −0.093 | −0.130 | |
Q | 6.150 | 1.752 | 6.155 | 1.783 | 8.325 | 7.209 | 6.924 | 9.659 | 6.145 | 1.466 | 1.730 | |
I 2 | 18.696 | 0 | 18.768 | 0 | 39.941 | 30.638 | 27.792 | 48.235 | 67.452* | 0 | 0 | |
Excluding Piano and Lazar studies | No. of comparison | 5 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 3 | 4 | 4 |
No. of H/C | 91/89 | 66/63 | 91/89 | 91/89 | 91/89 | 91/89 | 91/89 | 91/89 | 66/63 | 75/73 | 75/73 | |
SMD | −0.138 | 0.428* | −0.699*** | 0.443** | −0.003 | −0.412** | −0.426* | 0.410 | 0.260 | −0.093 | −0.130 | |
Q | 6.139 | 0.859 | 5.327 | 1.189 | 8.027 | 3.055 | 6.807 | 9.641 | 6.145 | 1.466 | 1.730 | |
I 2 | 34.842 | 0 | 24.913 | 0 | 50.169 | 0 | 41.236 | 58.511* | 67.452* | 0 | 0 | |
Adaptation | ||||||||||||
No | No. of comparison | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 4 | 4 | 4 |
No. of H/C | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 96/93 | 66/63 | 96/93 | 96/93 | 96/93 | |
SMD | −0.334 | 0.663* | −0.888* | 0.473 | 0.170 | −0.620 | −0.698* | 0.472 | 0.518 | 0.319 | −0.257 | |
Q | 18.619 | 9.082 | 17.607 | 1.321 | 3.143 | 15.691 | 12.338 | 5.671 | 15.010 | 17.535 | 1.010 | |
I 2 | 83.888*** | 66.969* | 82.962*** | 0 | 4.555 | 80.880** | 75.685** | 64.734 | 80.013** | 82.891** | 0 | |
Yes | No. of comparison | 3 | 1 | 3 | 3 | 3 | 3 | 3 | 3 | — | 1 | 1 |
No. of H/C | 56/51 | 31/25 | 56/51 | 56/51 | 56/51 | 56/51 | 56/51 | 56/51 | — | 9/10 | 9/10 | |
SMD | −0.232 | 0.740** | −0.847** | 0.397 | −0.306 | −0.384 | −0.375 | 0.337 | — | −0.500 | 0.322 | |
Q | 0.802 | 0 | 4.117 | 1.402 | 1.792 | 6.282 | 3.679 | 3.119 | — | 0 | 0 | |
I 2 | 0 | 0 | 51.426 | 0 | 0 | 68.161* | 45.633 | 35.880 | — | 0 | 0 | |
Between group difference | Q | 0.067 | 0.039 | 0.007 | 0.096 | 3.711 | 0.209 | 0.578 | 0.109 | — | 1.880 | 1.429 |
P | 0.795 | 0.843 | 0.933 | 0.756 | 0.054 | 0.647 | 0.447 | 0.741 | — | 0.170 | 0.232 | |
PSG scoring methods | ||||||||||||
AASM | No. of comparison | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
No. of H/C | 59/59 | 59/59 | 59/59 | 59/59 | 59/59 | 59/59 | 59/59 | 29/29 | 59/59 | 59/59 | 59/59 | |
SMD | −0.400 | 0.897 | −1.103 | 0.473* | 0.173 | −1.019 | −0.911 | 0.790** | 0.546 | 0.595 | −0.257 | |
Q | 18.489 | 6.438 | 16.406 | 1.307 | 3.013 | 8.528 | 8.922 | 0 | 13.008 | 14.898 | 0.524 | |
I 2 | 94.591*** | 84.467* | 93.905*** | 23.478 | 66.814 | 88.275** | 88.792** | 0 | 92.312*** | 93.288*** | 0 | |
R&K | No. of comparison | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 2 | 3 | 3 |
No. of H/C | 77/69 | 68/59 | 77/69 | 77/69 | 77/69 | 77/69 | 77/69 | 77/69 | 37/34 | 46/44 | 46/44 | |
SMD | −0.242 | 0.573** | −0.609*** | 0.414* | −0.059 | −0.117 | −0.543* | 0.449 | 0.526 | −0.055 | −0.135 | |
Q | 0.884 | 1.485 | 2.677 | 1.437 | 3.513 | 3.897 | 4.608 | 5.346 | 1.914 | 1.386 | 1.728 | |
I 2 | 0 | 0 | 0 | 0 | 14.604 | 23.008 | 34.893 | 43.882 | 47.755 | 0 | 0 | |
Between group difference | Q | 0.035 | 0.375 | 0.341 | 0.047 | 0.391 | 2.156 | 0.343 | 0.890 | 0.001 | 0.695 | 0.186 |
P | 0.852 | 0.540 | 0.559 | 0.828 | 0.532 | 0.142 | 0.558 | 0.346 | 0.980 | 0.404 | 0.666 |
AASM, American academy of sleep medicine; AHI, apnea hypopnea index; AI, arousal index; BMI, body mass index; Q, Cochran’s Q statistic; REM, rapid eye movement sleep, H/C, Huntington disease/control; PLMI, periodic limb movements index; R&K, Rechtschaffen and Kales; SWS, slow wave sleep; SE, sleep efficiency; TST, total sleep time.
*p < 0.05, **p < 0.01, ***p < 0.001.